Cefiderocol effective for carbapenem-resistant Gram-negative infections

The clinical and microbiological outcomes of cefiderocol, a new antibiotic, were similar to the best available therapy for patients with life-threatening carbapenem-resistant infections, a phase III study has suggested.
Source: The Pharmaceutical Journal - Category: Drugs & Pharmacology Source Type: research